-+ 0.00%
-+ 0.00%
-+ 0.00%

TransCode Therapeutics Submits IND Amendment for Phase 2a Trial of TTX-MC138 in Colorectal Cancer

Reuters·02/05/2026 13:05:32

Please log in to view news